Grand Pharmaceutical Group Limited (HK:0512) has released an update.
At the recent Annual General Meeting, Grand Pharmaceutical Group Limited reported overwhelming shareholder approval for all proposed resolutions, including the adoption of audited financial statements, director re-elections, and the declaration of a final dividend of HK$0.26 per share. Shareholders also granted the directors general mandates to issue and repurchase shares, indicating a strong confidence in the company’s leadership and future direction.
For further insights into HK:0512 stock, check out TipRanks’ Stock Analysis page.
